Skip to main content

Advertisement

Log in

The frailty in elderly patients receiving cardiac interventional procedures (FRASER) program: rational and design of a multicenter prospective study

  • Original Article
  • Published:
Aging Clinical and Experimental Research Aims and scope Submit manuscript

Abstract

Background

Frailty has become a high-priority issue in cardiovascular medicine because of the aging of cardiovascular patients. Simple and reproducible tools to assess frailty in elderly patients are clearly on demand. Their application may help physicians in the selection of invasive and medical treatments and in the timing and modality of the follow-up. The frailty in elderly patients receiving cardiac interventional procedures (FRASER) program is designed with the aim to validate the use of the short physical performance battery (SPPB) as prognostic tools in patients admitted to hospital for acute coronary syndrome (ACS).

Methods

The FRASER program is a multicenter prospective study involving 4 Italian cardiology units. The FRASER program enrolls only patients aged ≥70 years. The core of the FRASER program includes patients admitted to hospital for ACS. The aims are (1) to describe SPPB distribution before hospital discharge and (2) to investigate the prognostic role of SPPB score. The primary outcome is a composite of 1-year all-cause mortality and hospital readmission for any cause. Ancillary analyses will be focused on different study populations (patients hospitalized for arrhythmias or acute heart failure or symptomatic severe aortic stenosis) and on different tools to assess frailty (multidimensional prognostic index, clinical frailty score, grip strength).

Discussion

The FRASER program will fill critical gaps in the knowledge regarding the link between frailty, cardiovascular disease, interventional procedures and outcome and will help physicians in the generation of a more personalized risk assessment and in the identification of potential targets for interventions.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Sabetta T, Ricciardi W (2016) Health status of the Italian people: gender inequalities. Ann Ist Super Sanità 52:151–153

    PubMed  Google Scholar 

  2. http://www.who.int/gho/mortality_burden_disease/life_tables/situation_trends_text/en/ Last seen 19 July 2016

  3. Forman DE, Rich MW, Alexander KP et al (2011) Cardiac care for older adults: time for a new paradigm. JACC 57:1801–1810

    Article  Google Scholar 

  4. Bergman H, Ferrucci L, Guralnik J et al (2007) Frailty: an emerging research and clinical paradigm—issues and controversies. J Gerontol A Biol Sci Med Sci 62:731–737

    Article  Google Scholar 

  5. Fried LP, Tangen CM, Walston J et al (2001) Cardiovascular Health Study Collaborative Research Group. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 56:M146–M156

    Article  CAS  Google Scholar 

  6. Singh M, Stewart R, White H (2014) Importance of frailty in patients with cardiovascular disease. Eur Heart J 35:1726–1731

    Article  Google Scholar 

  7. Sergi G, Veronese N, Fontana L et al (2015) Pre-Frailty and risk of cardiovascular disease in elderly men and women. JACC 65:10

    Article  Google Scholar 

  8. Gambassi G, Cesari M, Tosato M et al (2013) In 6 minuti al cuore della fragilità: il test del cammino in cardiologia geriatrica. G Ital Cardiol 14(3 Suppl. 1):19S–25S

    Google Scholar 

  9. Chen PF, Wang DN, Chen K et al (2015) Outcomes of percutaneous coronary intervention in patients ≥75 years: one-center study in a Chinese patient group. J Geriatr Cardiol 12:626–633

    PubMed  PubMed Central  Google Scholar 

  10. Reeves GR, Whellan DJ, Patel MJ et al (2016) Comparison of frequency of frailty and severely impaired physical function in patients ≥60 years hospitalized with acute decompensated heart failure versus chronic stable heart failure with reduced and preserved left ventricular ejection fraction. Am J Cardiol 117:1953–1958

    Article  Google Scholar 

  11. Windecker S, Kolh P, Alfonso F et al (2014) 2014 ESC/EACTS guidelines on myocardial revascularization. Eur Heart J 35:2541–2619

    Article  Google Scholar 

  12. Guralnik J, Simonsick E, Ferrucci L et al (1994) A SPPB assessing lower extremity function: association with self reported disability and prediction of mortality and nursing home admission. J Gerontol Med Sci 42:85–94

    Article  Google Scholar 

  13. Guralnik JM, Ferrucci L, Simonsick EM et al (1995) Lower-extremity function in persons over the age of 70 years as a predictor of subsequent disability. N Engl J Med 332:556–561

    Article  CAS  Google Scholar 

  14. Volpato S, Cavalieri M, Sioulis F et al (2011) Predictive value of the short physical performance battery following hospitalization in older patients. J Gerontol A Biol Sci Med Sci 66:89–96

    Article  Google Scholar 

  15. Biscaglia S, Campo G, Pavasini R et al (2016) Occurrence, causes, and outcome after switching from ticagrelor to clopidogrel in a real-life scenario: data from a prospective registry. Platelets 27:484–487

    Article  CAS  Google Scholar 

  16. Campo G, Pavasini R, Malagù M et al (2015) Relationship between troponin elevation, cardiovascular history and adverse events in patients with acute exacerbation of COPD. COPD 12:560–567

    Article  Google Scholar 

  17. Tumscitz C, Pirani L, Tebaldi M et al (2014) Seven french radial artery access for PCI: a prospective single-center experience. Int J Cardiol 176:1074–1075

    Article  Google Scholar 

  18. Mehran R, Rao SV, Bhatt DL et al (2011) Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the bleeding academic research consortium. Circulation 123:2736–2747

    Article  Google Scholar 

  19. Cutlip DE, Windecker S, Mehran R et al (2007) Clinical end points in coronary stent trials: a case for standardized definitions. Circulation 115:2344–2351

    Article  Google Scholar 

  20. Roberts HC, Denison HJ, Martin HJ et al (2011) A review of the measurement of grip strength in clinical and epidemiological studies: towards a standardized approach. Age Ageing 40:423–429

    Article  Google Scholar 

  21. Pilotto A, Ferrucci L, Franceschi M et al (2008) Development and validation of a multidimensional prognostic index for one-year mortality from comprehensive geriatric assessment in hospitalized older patients. Rejuvenation Res 11:151–161

    Article  Google Scholar 

  22. Volpato S, Bazzano S, Fontana A et al (2015) Multidimensional prognostic index predicts mortality and length of stay during hospitalization in the older patients: a multicenter prospective study. J Gerontol A Biol Sci Med Sci 70:325–331

    Article  Google Scholar 

  23. Rockwood K, Song X, MacKnight C et al (2005) A global clinical measure of fitness and frailty in elderly people. CMAJ 173:489–495

    Article  Google Scholar 

  24. Campo G, Morciano G, Pavasini R et al (2016) Fo ATP synthase C subunit serum levels in patients with ST-segment Elevation Myocardial Infarction: preliminary findings. Int J Cardiol 9:993–997

    Article  Google Scholar 

  25. Campo G, Valgimigli M, Ferraresi P et al (2006) Tissue factor and coagulation factor VII levels during acute myocardial infarction: association with genotype and adverse events. Arterioscler Thromb Vasc Biol 26:2800–2806

    Article  CAS  Google Scholar 

  26. Campo G, Ferraresi P, Marchesini J et al (2011) Relationship between paraoxonase Q192R gene polymorphism and on-clopidogrel platelet reactivity over time in patients treated with percutaneous coronary intervention. J Thromb Haemost 9:2106–2108

    Article  CAS  Google Scholar 

  27. Campo G, Marchesini J, Bristot L et al (2012) The in vitro effects of verbascoside on human platelet aggregation. J Thromb Thrombolysis 34:318–325

    Article  CAS  Google Scholar 

  28. Valgimigli M, Tebaldi M, Campo G et al (2012) Prasugrel versus tirofiban bolus with or without short post-bolus infusion with or without concomitant prasugrel administration in patients with myocardial infarction undergoing coronary stenting: the FABOLUS PRO (Facilitation through Aggrastat By drOpping or shortening Infusion Line in patients with ST-segment elevation myocardial infarction compared to or on top of PRasugrel given at loading dOse) trial. JACC Cardiovasc Interv 5:268–277

    Article  Google Scholar 

  29. Campo G, Pavasini R, Biscaglia S et al (2015) Platelet aggregation values in patients with cardiovascular risk factors are reduced by verbascoside treatment. A randomized study. Pharmacol Res 97:1–6

    Article  CAS  Google Scholar 

  30. Garg S, Sarno G, Girasis C et al (2011) A patient-level pooled analysis assessing the impact of the SYNTAX score on 1-year clinical outcomes in 6,508 patients enrolled in contemporary coronary stent trials. JACC Cardiovasc Interv 4:645–653

    Article  Google Scholar 

  31. Garg S, Sarno G, Serruys PW et al (2011) Prediction of 1-year clinical outcomes using the SYNTAX score in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a substudy of the STRATEGY and MULTISTRATEGY trials. JACC Cardiovasc Interv 4:66–75

    Article  Google Scholar 

  32. Kobayashi Y, Nam CW, Tonino PA et al (2016) the prognostic value of residual coronary stenoses after functionally complete revascularization. J Am Coll Cardiol 67:1701–1711

    Article  Google Scholar 

  33. Purser JL, Weinberger M, Cohen HJ et al (2005) Walking speed predicts health status and hospital costs for frail elderly male veterans. J Rehabil Res Dev 42:535–546

    Article  Google Scholar 

  34. Quadri P, Tettamanti M, Bernasconi S et al (2005) Lower limb function as predictor of falls and loss of mobility with social repercussions one year after discharge among elderly inpatients. Aging Clin Exp Res 17:82–89

    Article  Google Scholar 

  35. Atkinson HH, Rosano C, Simonsick EM et al (2007) Cognitive function, gait speed decline, and comorbidities: the health, aging and body composition study. J Gerontol A Biol Sci Med Sci 62:844–850

    Article  Google Scholar 

  36. Forrest KYZ, Zmuda JM, Cauley JA (2006) Correlates of decline in lower extremity performance in older women: a 10-year follow-up study. J Gerontol A Biol Sci Med Sci 61:1194–1200

    Article  Google Scholar 

  37. Volpato S, Ble A, Metter EJ et al (2008) High-density lipoprotein cholesterol and objective measures of lower extremity performance in older nondisabled persons: the InChianti study. J Am Geriatr Soc 56:621–629

    Article  Google Scholar 

  38. Volpato S, Leveille SG, Corti MC et al (2001) The value of serum albumin and high-density lipoprotein cholesterol in defining mortality risk in older persons with low serum cholesterol. J Am Geriatr Soc 49:1142–1147

    Article  CAS  Google Scholar 

  39. Huffman JC, Beale EE, Celano CM et al (2016) Effects of optimism and gratitude on physical activity, biomarkers, and readmissions after an acute coronary syndrome: the gratitude research in acute coronary events study. Circ Cardiovasc Qual Outcomes 9:55–63

    Article  Google Scholar 

  40. Turkstra E, Hawkes AL, Oldenburg B et al (2013) Cost-effectiveness of a coronary heart disease secondary prevention program in patients with myocardial infarction: results from a randomised controlled trial (ProActive Heart). BMC Cardiovasc Disord 13:33

    Article  Google Scholar 

  41. Pahor M, Blair SN, Espeland M et al (2006) Effects of a physical activity intervention on measures of physical performance: results of the lifestyle interventions and independence for Elders Pilot (LIFE-P) study. J Gerontol A Biol Sci Med Sci 61:1157–1165

    Article  Google Scholar 

  42. Campo G, Saia F, Guastaroba P et al (2011) Prognostic impact of hospital readmissions after primary percutaneous coronary intervention. Arch Intern Med 171:1948–1949

    Article  Google Scholar 

  43. Ferreiro JL, Angiolillo DJ (2012) New directions in antiplatelet therapy. Circ Cardiovasc Interv 5:433–445

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Gianluca Campo.

Ethics declarations

Conflict of interest

The authors report no relationships that could be construed as a conflict of interest.

Funding/support

The study was an investigator driven clinical trial conducted by the University of Ferrara.

Ethical approval

All procedures were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Ethics committee of the four participating institutions approved the protocol, and enrolled patients gave written informed consent before inclusion.

Statement of human and animal rights

This study was approved by the Ethical Review Committee of our hospital.

Informed consent

All participants will sign the consent at the time of the enrollment.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOCX 84 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Campo, G., Pavasini, R., Maietti, E. et al. The frailty in elderly patients receiving cardiac interventional procedures (FRASER) program: rational and design of a multicenter prospective study. Aging Clin Exp Res 29, 895–903 (2017). https://doi.org/10.1007/s40520-016-0662-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40520-016-0662-y

Keywords

Navigation